-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

615.O2.6 615. Acute Myeloid Leukemia: Commercially Available Therapy, excluding Transplantation: Commercially Available Therapy, excluding Transplantation II

Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Adult, AML, apoptosis, Leukemia, Diseases, Non-Biological, Combinations, Elderly, Therapies, chemotherapy, Biological Processes, Study Population, Clinically relevant, Myeloid Malignancies
Monday, December 7, 2020: 11:30 AM-1:00 PM
Moderators:
Adriano Venditti, MD , Fondazione Policlinico Tor Vergata and Bhumika J. Patel, MD, Cleveland Clinic, Cleveland Clinic, Cleveland Clinic
Disclosures:
Venditti: Novartis: Consultancy, Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES (paid by any for-profit health care company); Pfizer: Consultancy, Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES (paid by any for-profit health care company), Speakers Bureau; Amgen: Consultancy, Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES (paid by any for-profit health care company); Jazz: Consultancy, Honoraria, Other: TRAVEL, ACCOMMODATIONS, EXPENSES (paid by any for-profit health care company); AbbVie: Consultancy, Honoraria, Other: TRAVEL, ACCOMODATIONS, EXPENSES (paid by any for-profit health care company); Janssen: Consultancy, Honoraria, Other: TRAVEL, ACCOMODATIONS, EXPENSES (paid by any for-profit health care company). Patel: Alexion: Other: educational speaker, Speakers Bureau.
11:30 AM

Jorge Sierra, MD1, Pau Montesinos, MD, PhD2,3*, Xavier Thomas, MD, PhD4, Laimonas Griškevičius, MD, PhD5,6*, Thomas Cluzeau, MD, PhD7,8,9,10*, Denis Caillot11*, Ollivier Legrand, MD12,13,14*, Clara Minotti, MD15*, Mario Luppi16*, Firas Farkas, MD17*, Bourras-Rezki Bengoudifa, MS18*, Geralyn Gilotti, MSc18*, Sejla Hodzic, MD18*, Alessandro Rambaldi, MD, PhD19* and Adriano Venditti, MD 20

1Hematology Department, Hospital de la Santa Creu i Sant Pau, Sant Pau Biomedical Research (IIB) and Jose Carreras Leukemia Research Institutes, Autonomous University of Barcelona, Barcelona, Spain
2Hospital Universitari i Politècnic La Fe, Valencia, Spain
3CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
4Department of Hematology, Hospices Civils de Lyon, Lyon-Sud Hospital, Pierre-Bénite, Lyon, France
5Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, Vilnius, Lithuania
6Hematology, Oncology and Transfusion Medicine Center, Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania
7Hematology Department, CHU of Nice, Cote D’Azur University, Nice, France
8Sophia Antipolis University, Nice, France
9Equipe Labellisée par la Ligue Nationale Contre le Cancer, Paris, France
10INSERM U1065, Mediterranean Center of Molecular Medicine, Cote D’Azur University, Nice, France
11Hematology Department, Dijon University Hospital, Dijon, France
12UMRS 938, INSERM, Paris, France
13Department of Hematology and Cellular Therapy, Saint Antoine Hospital, AP-HP, Paris, France
14Université Pierre et Marie Curie Paris VI, Sorbonne University, Paris, France
15Hematology, Department of Translational and Precision Medicine, Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
16Department of Medical and Surgical Sciences, Section of Hematology, University of Modena and Reggio Emilia, Modena, Italy
17Department of Hematology and Transfusion Medicine, University Hospital, Bratislava, Slovakia
18Novartis Pharmaceuticals Corporation, East Hanover, NJ
19Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
20Fondazione Policlinico Tor Vergata, Rome, Italy

11:45 AM

Timothy S. Pardee, MD, PhD1, Kristin M. Pladna, M.S.2*, Susan Lyerly, P.A.-C.2*, Sarah Dralle2*, Megan Manuel, NP2*, Leslie Renee Ellis, MD, MSHPEd2, Dianna S. Howard, MD2, Rupali Bhave, M.D.2* and Bayard L. Powell, MD2

1Comprehensive Cancer Center of Wake Forest Baptist Medical Center, Winston Salem, NC
2Comprehensive Cancer Center of Wake Forest Baptist Health, Winston-Salem, NC

12:00 PM

Jorge Labrador1*, David Martínez-Cuadrón, MD2,3*, Adolfo de la Fuente4*, Rebeca Rodríguez-Veiga, MD2,5*, Josefina Serrano, MD6*, Mar Tormo, MD7, Jose Antonio Pérez-Simón, MD8*, Fernando Ramos9*, Teresa Bernal del Castillo, MD, PhD10*, Maria López-Pavía11*, Fernanda Trigo12*, Pilar Martinez Sanchez13*, Juan Ignacio Rodriguez-Gutierrez14*, Carlos Rodriguez15*, Cristina Gil16*, Daniel Garcia17*, Susana Vives, MD18*, Maria Angeles Foncillas19*, Manuel Perez Encinas, MD20*, Andrés Novo, MD21*, Isabel Recio22*, Gabriela Rodriguez-Macías, MD23*, Juan Miguel Bergua Burgues, MD24*, Victor Noriega Concepcion25*, Esperanza Lavilla26*, Alicia Roldán Pérez27*, Miguel A. Sanz, MD2,3,28 and Pau Montesinos, MD, PhD28,29,30*

1Hematology Department, Research Unit, Hospital Universitario de Burgos, Burgos, Spain
2CIBERONC Instituto de Salud Carlos III, Madrid, Spain
3Hematology and hemotherapy department, Hospital Universitari i Politècnic La Fe, Valencia, Spain
4MD Anderson Cancer Center, Madrid, Spain
5Hospital Universitari i Politécnic La Fe, Valencia, Spain
6Clinical Hematology, Hospital Universitario Reina Sofía, Córdoba, Spain
7Hospital Clínico Universitario de Valencia, Valencia, Spain
8Department of Hematology, Hospital Universitario Virgen del Rocio; Instituto de Biomedicina de Sevilla (IBIS)/CSIC/Universidad de Sevilla,Spain, Sevilla, Spain
9Hematology Department, Hospital Universitario de León, León, Spain, León, Spain
10Hospital Universitario Central Asturias, ISPA, IUOPA, Oviedo, Spain
11Hospital General Universitari de València, Hematology Service, Valencia, Spain
12Dept. of Clinical Hematology, Centro Hospitalar Universitário de São João, Porto, Portugal
13Clinical Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
14Hospital Universitario Basurto, Bilbao, Spain
15Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain
16Hematology Department, Hospital General Universitario de Alicante, Alicante, Spain
17Hematology Department, Hospital Sanitas La Zarzuela, Madrid, Spain
18Hematology Department, ICO - Hospital Germans Trias i Pujol, Badalona, Spain
19Hematology Department, Hospital Universitario Infanta Leonor, Madrid, Spain
20Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain
21Hematology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain
22Hematology Deparment, Complejo Asistencial de Ávila, Avila, Spain
23Hematology and hemotherapy department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
24Hematology and hemotherapy department, Hospital San Pedro de Alcántara, Cáceres, Spain
25Hospital Universitario de A Coruña, A CoruñA, ESP
26Hospital Universitario Lucus Augusti, Lugo, Spain
27Hematology and hemotherapy department, Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain
28Programa Español de Tratamientos en Hematologia, PETHEMA, Valencia, Spain
29CIBERONC, Instituto de Salud Carlos III, Madrid, Spain
30Hematology Department, Hospital Universitario La Fe de Valencia,, Valencia, Spain, Spain

12:15 PM

Jeffrey E. Lancet, MD1, Geoffrey L Uy, MD2, Laura F. Newell, MD3, Tara Lin, MD4, Donna E. Hogge5*, Scott R. Solomon, MD6, Gary J. Schiller, MD7, Matthew J. Wieduwilt, MD, PhD8, Daniel H. Ryan9, Stefan Faderl10, Yu-Lin Chang10* and Jorge E. Cortes, MD11,12

1H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
2Washington University School of Medicine, Saint Louis, MO
3Oregon Health & Science University, Portland, OR
4University of Kansas Medical Center, Kansas City, KS
5Leukemia/BMT Program of British Columbia, Vancouver, BC, Canada
6Leukemia Program, Northside Hospital Cancer Center Institute, Atlanta, GA
7David Geffen School of Medicine at UCLA, Los Angeles, CA
8University of California – San Diego Moores Cancer Center, La Jolla, CA
9University of Rochester, Rochester, NY
10Jazz Pharmaceuticals, Palo Alto, CA
11Georgia Cancer Center, Augusta University, Augusta, GA
12The University of Texas MD Anderson Cancer Center, Houston, TX

12:30 PM

Eytan M. Stein, MD1, Ying Huang, MS, MA2*, Uma Borate3, Maria R. Baer, M.D.4, Wendy Stock, MD5, Tibor Kovacsovics, MD6, William Blum, MD7, Gary J. Schiller, MD8, Rebecca L. Olin, MD9, James M. Foran, MD10, Mark Litzow, MD11, Tara Lin, MD12, Prapti Patel, MD13, Matthew C Foster, MD14, Michael Boyiadzis, MD15, Robert H. Collins, MD16, Jo-Anne Vergilio, M.D.17*, Nyla A Heerema, PhD18, Leonard Rosenberg19*, Ashley Owen Yocum, PhD20*, Timothy Chen, PhD21*, Franchesca Druggan, MSc22*, Sonja Marcus, MPH23*, Mona Stefanos, MBChB24*, Jordan Chervin25*, Abigail Shoben26*, Brian J. Druker, MD27, Amy Burd, PhD28, John C. Byrd, MD29, Ross L. Levine, MD25 and Alice S. Mims, MD26

1Division of Hematologic Oncology, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
2The Ohio State University James Comprehensive Cancer Center, Columbus, OH
3Oregon Health & Science University, Portland, OR
4Greenebaum Comprehensive Cancer Center, University of Maryland School of Medicine, Baltimore, MD
5University of Chicago Medical Center, Chicago, IL
6Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute - University Of Utah, Salt Lake City, UT
7Department of Hematology and Medical Oncology, Emory University, Atlanta, GA
8UCLA David Geffen School of Medicine, Los Angeles, CA
9Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
10Mayo Clinic, Jacksonville, FL
11Mayo Clinic, Rochester, MN
12Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas, Kansas City, KS
13University of Texas Southwestern Medical Center, Dallas, TX
14Lineberger Comprehensive Cancer Center, UNC, Chapel Hill, Chapel Hill, NC
15Univ. of Pittsburgh Cancer Inst., Pittsburgh, PA
16Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
17Foundation Medicine, Inc., Cambridge, MA
18Department of Pathology, The Ohio State University, Columbus, OH
19Leukemia & Lymphoma Society, Mount Laurel, NJ
20Leukemia and Lymphoma Society, New York
21Department of Internal Medicine, Division of Hematology, College of Medicine, The Ohio State University, Columbus, OH
22The Ohio State University, Columbus, OH
23Leukemia & Lymphoma Society, Rye Brook, NY
24Leukemia & Lymphoma Society, Columbus, OH
25Memorial Sloan Kettering Cancer Center, New York, NY
26The Ohio State University Comprehensive Cancer Center, Columbus, OH
27Knight Cancer Institute, Division of Hematology & Medical Oncology, Oregon Health & Science University, Portland, OR
28Leukemia and Lymphoma Society, White Plains, NY
29Division of Hematology, The Ohio State University, Columbus, OH

12:45 PM

Abhishek Maiti, MBBS1, Courtney D. DiNardo, MD, MSc2, Tapan M. Kadia, MD3, Elias Jabbour, MD1, Caitlin R. Rausch, PharmD4*, Naval Daver, MD5, Gautam Borthakur, MD1, Naveen Pemmaraju, MD1, Nicholas J. Short, MD1, Musa Yilmaz, MD6, Yesid Alvarado, MD6, Kathryn S Montalbano, RN1*, Allison Wade7*, Rita Maduike8*, Julio A Guerrero, RN1*, Kenneth Vaughan, RN1*, Carol A. Bivins, RN1*, Sherry A. Pierce, BSN, BA1*, Farhad Ravandi, MBBS9, Hagop M. Kantarjian, MD10 and Marina Konopleva, MD, PhD11

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, UT MD Anderson Cancer Center, Houston, TX
3Department of Leukemia, M.D. Anderson Cancer Center, Houston, TX
4Pharmacy, MD Anderson Cancer Center, Houston, TX
5Department of Leukemia, The University of Texas, M.D. Anderson Cancer Center, Houston, TX
6Department of Leukemia, MD Anderson Cancer Center, Houston, TX
7The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX
9Department of Leukemia, University of Texas- MD Anderson Cancer Center, Houston, TX
10University of Texas MD Anderson Cancer Center, Houston, TX
11Department of Leukemia, University of Texas, MD Anderson Cancer Center, Houston, TX

*signifies non-member of ASH